Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNC
901
DELISTED
Arconic Corporation
ARNC
| $4.91M | 0.01% |
231,982
+73,842
| +47% | +$1.54M |
|
902
Ducommun
DCO
$2.78B
| $4.9M | 0.01% |
98,053
+14,087
| +17% | +$671K |
|
903
Conduent
CNDT
$250M
| $4.9M | 0.01% |
1,208,791
+216,164
| +22% | +$829K |
|
904
Cousins Properties
CUZ
$4.94B
| $4.89M | 0.01% |
193,497
+64,756
| +50% | +$1.58M |
|
|
GMS
905
DELISTED
GMS Inc
GMS
| $4.89M | 0.01% |
98,159
+8,777
| +10% | +$421K |
|
906
Sabre
SABR
$912M
| $4.86M | 0.01% |
812,333
+480,435
| +145% | +$2.68M |
|
|
ACH
907
Accendra Health
ACH
$89.2M
| $4.86M | 0.01% |
248,688
+187,742
| +308% | +$3.66M |
|
908
Crocs
CROX
$6.03B
| $4.85M | 0.01% |
45,555
+37,432
| +461% | +$3.31M |
|
909
JetBlue
JBLU
$1.87B
| $4.82M | 0.01% |
752,928
-184,830
| -20% | -$1.35M |
|
910
Fulgent Genetics
FLGT
$535M
| $4.81M | 0.01% |
161,451
+65,682
| +69% | +$2.35M |
|
911
JELD-WEN Holding
JELD
$216M
| $4.81M | 0.01% |
498,214
+137,173
| +38% | +$1.33M |
|
912
Hilltop Holdings
HTH
$2.22B
| $4.8M | 0.01% |
160,083
-32,403
| -17% | -$922K |
|
|
DHIL
913
DELISTED
Diamond Hill
DHIL
| $4.8M | 0.01% |
25,930
+989
| +4% | +$176K |
|
914
Medifast
MED
$134M
| $4.8M | 0.01% |
41,583
+29,369
| +240% | +$3.42M |
|
915
Tactile Systems Technology
TCMD
$529M
| $4.78M | 0.01% |
416,662
-89,542
| -18% | -$788K |
|
916
Etsy
ETSY
$7.99B
| $4.78M | 0.01% |
39,879
+24,566
| +160% | +$2.81M |
|
917
Fortive
FTV
$18.3B
| $4.77M | 0.01% |
98,795
-15,452
| -14% | -$748K |
|
918
KRONOS Worldwide
KRO
$1B
| $4.75M | 0.01% |
505,213
+388,915
| +334% | +$3.68M |
|
|
MDC
919
DELISTED
M.D.C. Holdings, Inc.
MDC
| $4.74M | 0.01% |
150,016
+58,792
| +64% | +$1.82M |
|
920
Kirby Corp
KEX
$7.32B
| $4.74M | 0.01% |
74,321
+3,919
| +6% | +$262K |
|
921
RLJ Lodging Trust
RLJ
$1.76B
| $4.74M | 0.01% |
447,387
+172,363
| +63% | +$1.95M |
|
922
Option Care Health
OPCH
$3.55B
| $4.73M | 0.01% |
157,257
-36,952
| -19% | -$1.15M |
|
923
Kohl's
KSS
$2.08B
| $4.72M | 0.01% |
188,652
-23,953
| -11% | -$679K |
|
924
Arista Networks
ANET
$237B
| $4.7M | 0.01% |
156,232
-213,908
| -58% | -$6.58M |
|
925
MasterBrand
MBC
$1.9B
| $4.67M | 0.01% |
+628,533
| New | +$5.15M |
|
Similar funds
Cliff Asness's Q4 2022 Portfolio in Review
As of Q4 2022, Cliff Asness held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- Cliff Asness added most to Humana in Q4 2022, an estimated $111M increase.
- Cliff Asness's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- Cliff Asness fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- Cliff Asness's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- Cliff Asness opened 170 new positions and closed 150 in Q4 2022.
- Cliff Asness's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.